Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1986 Jun;53(6):805–810. doi: 10.1038/bjc.1986.136

Importance of quantitative histology of bone changes in monoclonal gammopathy.

R Bataille, D Chappard, C Alexandre, P Dessauw, J Sany
PMCID: PMC2001420  PMID: 3718833

Abstract

Quantitative histology of bone changes, using undecalcified transiliac bone biopsies (UTBB), was performed blindly in 46 individuals with monoclonal gammopathy (MG), including 17 with MG of undetermined significance (MGUS) and 29 with overt multiple myeloma (MM). Three MGUS presented an excess of osteoclastic resorption (OR) in the vicinity of clusters of tumour cells and developed overt B cell malignancies, chronic lymphocytic leukaemia, Waldenström's disease and MM respectively. On the other hand, MGUS with normal OR remained stable (median follow-up = 28 months), with one exception who developed a systemic amyloidosis. In MM, excessive OR was only observed in areas invaded by myeloma cells. OR was frequently normal in active MM lacking myeloma cells in UTBB. Active MM without lesions on radiography had excessive OR. IgA and pure Bence Jones MM appeared more osteoclastic than IgG cases (P less than 0.05). Of major interest was the finding that one third of MM presented histological bone changes similar to osteoporosis, osteosclerosis or osteoblastic metastasis. Two major findings must be emphasized from the current data: UTBB could be of major interest for the early detection of a B cell malignancy; heterogeneity of myeloma bone condition is unexpected. If some changes appear directly related to the tumour (i.e. excessive OR or osteoblastic dysfunction), some others are probably accidentally associated with it (i.e. osteoporosis), both needing treatment other than chemotherapy.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bataille R., Chevalier J., Rossi M., Sany J. Bone scintigraphy in plasma-cell myeloma. A prospective study of 70 patients. Radiology. 1982 Dec;145(3):801–804. doi: 10.1148/radiology.145.3.6292996. [DOI] [PubMed] [Google Scholar]
  2. Bataille R., Sany J. Clinical evaluation of myeloma osteoclastic bone lesions: II. Induced hypocalcemia test using salmon calcitonin. Metab Bone Dis Relat Res. 1982;4(1):39–42. doi: 10.1016/0221-8747(82)90007-8. [DOI] [PubMed] [Google Scholar]
  3. Boccadoro M., Gavarotti P., Fossati G., Pileri A., Marmont F., Neretto G., Gallamini A., Volta C., Tribalto M., Testa M. G. Low plasma cell 3(H) thymidine incorporation in monoclonal gammopathy of undetermined significance (MGUS), smouldering myeloma and remission phase myeloma: a reliable indicator of patients not requiring therapy. Br J Haematol. 1984 Dec;58(4):689–696. doi: 10.1111/j.1365-2141.1984.tb06116.x. [DOI] [PubMed] [Google Scholar]
  4. Buonocore E., Solomon A., Kerley H. E. Pseudomyeloma. Radiology. 1970 Apr;95(1):41–46. doi: 10.1148/95.1.41. [DOI] [PubMed] [Google Scholar]
  5. Canellos G. P. Hypercalcemia in malignant lymphoma and leukemia. Ann N Y Acad Sci. 1974;230:240–246. doi: 10.1111/j.1749-6632.1974.tb14454.x. [DOI] [PubMed] [Google Scholar]
  6. Chappard D., Alexandre C., Camps M., Montheard J. P., Riffat G. Embedding iliac bone biopsies at low temperature using glycol and methyl methacrylates. Stain Technol. 1983 Sep;58(5):299–308. doi: 10.3109/10520298309066802. [DOI] [PubMed] [Google Scholar]
  7. Chappard D., Alexandre C., Riffat G. Histochemical identification of osteoclasts. Review of current methods and reappraisal of a simple procedure for routine diagnosis on undecalcified human iliac bone biopsies. Basic Appl Histochem. 1983;27(2):75–85. [PubMed] [Google Scholar]
  8. Cohen H. J., Silberman H. R., Tornyos K., Bartolucci A. A. Comparison of two long-term chemotherapy regimens, with or without agents to modify skeletal repair, in multiple myeloma. Blood. 1984 Mar;63(3):639–648. [PubMed] [Google Scholar]
  9. Delmas P. D., Charhon S., Chapuy M. C., Vignon E., Briancon D., Edouard C., Meunier P. J. Long-term effects of dichloromethylene diphosphonate (CI2MDP) on skeletal lesions in multiple myeloma. Metab Bone Dis Relat Res. 1982;4(3):163–168. doi: 10.1016/0221-8747(82)90013-3. [DOI] [PubMed] [Google Scholar]
  10. Durie B. G., Salmon S. E. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer. 1975 Sep;36(3):842–854. doi: 10.1002/1097-0142(197509)36:3<842::aid-cncr2820360303>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  11. Durie B. G., Salmon S. E., Mundy G. R. Relation of osteoclast activating factor production to extent of bone disease in multiple myeloma. Br J Haematol. 1981 Jan;47(1):21–30. doi: 10.1111/j.1365-2141.1981.tb02758.x. [DOI] [PubMed] [Google Scholar]
  12. Gailani S., McLimans W. F., Mundy G. R., Nussbaum A., Roholt O., Zeigel R. Controlled environment culture of bone marrow explants from human myeloma. Cancer Res. 1976 Apr;36(4):1299–1304. [PubMed] [Google Scholar]
  13. Greipp P. R., Kyle R. A. Clinical, morphological, and cell kinetic differences among multiple myeloma, monoclonal gammopathy of undetermined significance, and smoldering multiple myeloma. Blood. 1983 Jul;62(1):166–171. [PubMed] [Google Scholar]
  14. Kyle R. A., Greipp P. R. Smoldering multiple myeloma. N Engl J Med. 1980 Jun 12;302(24):1347–1349. doi: 10.1056/NEJM198006123022405. [DOI] [PubMed] [Google Scholar]
  15. Kyle R. A. Monoclonal gammopathy of undetermined significance. Natural history in 241 cases. Am J Med. 1978 May;64(5):814–826. doi: 10.1016/0002-9343(78)90522-3. [DOI] [PubMed] [Google Scholar]
  16. Maldonado J. E., Riggs B. L., Bayrd E. D. Pseudomyeloma. Is association of severe osteoporosis with serum monoclonal gammopathy an entity or a coincidence? Arch Intern Med. 1975 Feb;135(2):267–270. doi: 10.1001/archinte.135.2.267. [DOI] [PubMed] [Google Scholar]
  17. Maldonado J. E., Velosa J. A., Kyle R. A., Wagoner R. D., Holley K. E., Salassa R. M. Fanconi syndrome in adults. A manifestation of a latent form of myeloma. Am J Med. 1975 Mar;58(3):354–364. doi: 10.1016/0002-9343(75)90601-4. [DOI] [PubMed] [Google Scholar]
  18. Mundy G. R., Raisz L. G., Cooper R. A., Schechter G. P., Salmon S. E. Evidence for the secretion of an osteoclast stimulating factor in myeloma. N Engl J Med. 1974 Nov 14;291(20):1041–1046. doi: 10.1056/NEJM197411142912001. [DOI] [PubMed] [Google Scholar]
  19. Nakanishi T., Sobue I., Toyokura Y., Nishitani H., Kuroiwa Y., Satoyoshi E., Tsubaki T., Igata A., Ozaki Y. The Crow-Fukase syndrome: a study of 102 cases in Japan. Neurology. 1984 Jun;34(6):712–720. doi: 10.1212/wnl.34.6.712. [DOI] [PubMed] [Google Scholar]
  20. Radl J., Croese J. W., Zurcher C., van den Enden-Vieveen M. H., Brondijk R. J., Kazil M., Haaijman J. J., Reitsma P. H., Bijvoet O. L. Influence of treatment with APD-bisphosphonate on the bone lesions in the mouse 5T2 multiple myeloma. Cancer. 1985 Mar 1;55(5):1030–1040. doi: 10.1002/1097-0142(19850301)55:5<1030::aid-cncr2820550518>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  21. Raisz L. G., Luben R. A., Mundy G. R., Dietrich J. W., Horton J. E., Trummel C. L. Effect of osteoclast activating factor from human leukocytes on bone metabolism. J Clin Invest. 1975 Aug;56(2):408–413. doi: 10.1172/JCI108106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Rossi J. F., Bataille R. In vitro osteolytic activity of human myeloma plasma cells and the clinical evaluation of myeloma osteoclastic bone lesions. Br J Cancer. 1984 Jul;50(1):119–121. doi: 10.1038/bjc.1984.147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Rossi J. F., Bataille R. Unusual B-cell cancers that produce bone-resorbing factors and can mimic multiple myeloma. N Engl J Med. 1985 May 2;312(18):1192–1192. doi: 10.1056/NEJM198505023121816. [DOI] [PubMed] [Google Scholar]
  24. Valentin-Opran A., Charhon S. A., Meunier P. J., Edouard C. M., Arlot M. E. Quantitative histology of myeloma-induced bone changes. Br J Haematol. 1982 Dec;52(4):601–610. doi: 10.1111/j.1365-2141.1982.tb03936.x. [DOI] [PubMed] [Google Scholar]
  25. Woolfenden J. M., Pitt M. J., Durie B. G., Moon T. E. Comparison of bone scintigraphy and radiography in multiple myeloma. Radiology. 1980 Mar;134(3):723–728. doi: 10.1148/radiology.134.3.7355226. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES